0001209191-22-022570.txt : 20220404
0001209191-22-022570.hdr.sgml : 20220404
20220404172948
ACCESSION NUMBER: 0001209191-22-022570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220331
FILED AS OF DATE: 20220404
DATE AS OF CHANGE: 20220404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PASSERI DANIEL R
CENTRAL INDEX KEY: 0001190121
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 22803952
MAIL ADDRESS:
STREET 1: C/O CURIS INC
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-31
0
0001645460
Cue Biopharma, Inc.
CUE
0001190121
PASSERI DANIEL R
C/O CUE BIOPHARMA, INC.
21 ERIE STREET
CAMBRIDGE
MA
02139
1
1
0
0
CHIEF EXECUTIVE OFFICER
Common Stock
2022-03-31
4
M
0
75000
A
173700
D
Common Stock
2022-03-31
4
F
0
32122
4.88
D
141578
D
Common Stock
2022-03-31
5
G
0
E
10000
0.00
D
131578
D
Restricted Stock Units
2022-03-31
4
M
0
75000
0.00
D
Common Stock
75000
0
D
Represents shares of common stock received upon vesting of a restricted stock unit award.
Each restricted stock unit award represents a contingent right to receive one share of common stock.
One half of the Restricted Stock Units vested on September 30, 2021 and the balance vested on March 31, 2022.
/s/ Daniel Passeri by Colin Sandercock, attorney-in-fact
2022-04-04